Salesforce Inc. announced that Novartis, a global innovative medicines company, has selected Salesforce's Agentforce Life Sciences for Customer Engagement. Novartis plans to implement the Agentforce 360 for Life Sciences platform globally over the next five years. The rollout aims to unify engagement across marketing, sales, patient services, medical, market access, and other service stakeholders, with a focus on integrating compliance capabilities and customer insights through AI and data harmonization. This initiative builds upon Novartis's existing investments in various Salesforce solutions, including Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences, and Agentforce Marketing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Salesforce Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251217141127) on December 17, 2025, and is solely responsible for the information contained therein.